13F HOLDINGS REPORT
Essex Woodlands Management, Inc.
Quarter ended Q4 2023 · Filed November 14, 2023 · Accession 0001398344-23-020611
Total Value
$113.4M
Positions
6
Other Managers
0
Confidential Omitted
No
Holdings (6)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BIOVENTUS | BVS | 13,021,324 | $43.0M | 37.88% |
| 2 | TELA BIO, INC. | TELA | 4,110,709 | $32.9M | 28.99% |
| 3 | EYEPOINT PHARMACEUTICALS INC | EYPT | 3,490,921 | $27.9M | 24.59% |
| 4 | REVANCE THERAPEUTICS INC | 761330109 | 457,085 | $5.2M | 4.62% |
| 5 | MEDICINOVA INC | MNOV | 1,105,941 | $2.3M | 2.04% |
| 6 | VENUS CONCEPT, INC. | VERO | 1,089,195 | $2.1M | 1.88% |